Related Experiment Video
Updated: Jan 28, 2026

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
Published on: September 19, 2025
ErbB3 Ligand Heregulin1 Is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation
Shiqi Ma1, Shijun Jia2, Yuan Ren1
1Department of Basic Research, Sichuan Cancer Hospital/Institute, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610041.
Abstract:
There are seven ligands for the epidermal growth factor receptor (EGFR) ErbB1 and two ligands for ErbB3. EGFR can form a homodimer or a heterodimer with ErbB3. In this study, we investigated whether homodimers or heterodimers, and which ligand, play a major role in cancer development, with the goal of ultimately identifying therapeutic targets. We demonstrated that the ErbB3 ligand heregulin1 is the strongest mitogenic factor for non-small cell lung cancer cells and is more potent in activating EGFRmut-ErbB3 heterodimers than EGFRwt-ErbB3 heterodimers. We discovered that four of the seven EGFR ligands inhibited heregulin1-induced EGFRwt-ErbB3 activation and cell proliferation by promoting dephosphorylation of heregulin1-induced ErbB3 phosphorylation, whereas the other three did not exhibit such inhibition. Importantly, those four EGFR ligands did not inhibit heregulin1-induced EGFRmut-ErbB3 activation and proliferation of cells with EGFR mutants. We demonstrated that ErbB3 was overexpressed in the lung cancer cells but not in the adjacent normal alveoli or stromal tissue. EGFR and heregulin1 were also highly expressed in lung cancer cells. We conclude that the overexpression of heregulin1, ErbB3, and EGFR mutant renders uncontrolled cell proliferation.
Insights
Heregulin1 strongly drives non-small cell lung cancer (NSCLC) cell proliferation by activating epidermal growth factor receptor (EGFR)-ErbB3 heterodimers. Certain EGFR ligands inhibit this activation in wild-type EGFR but not in EGFR mutants, suggesting targeted therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Epidermal Growth Factor Receptor (EGFR) signaling is crucial in cell growth and cancer.
- EGFR can form homodimers or heterodimers, notably with ErbB3.
- Ligand-specific activation of these dimers influences cancer cell behavior.
Purpose of the Study:
- To determine the role of EGFR homodimers versus heterodimers in cancer development.
- To identify specific ligands that drive cancer proliferation.
- To uncover potential therapeutic targets for lung cancer.
Main Methods:
- Investigated the effects of various EGFR ligands on non-small cell lung cancer (NSCLC) cells.
- Compared the activation of wild-type EGFR (EGFRwt)-ErbB3 and mutant EGFR (EGFRmut)-ErbB3 heterodimers.
- Assessed the impact of EGFR ligands on heregulin1-induced cell proliferation and phosphorylation.
Main Results:
- Heregulin1 was identified as the most potent mitogenic factor for NSCLC cells.
- Heregulin1 more potently activated EGFRmut-ErbB3 heterodimers than EGFRwt-ErbB3 heterodimers.
- Four of seven EGFR ligands inhibited heregulin1-induced EGFRwt-ErbB3 activation but not EGFRmut-ErbB3 activation.
- ErbB3, EGFR, and heregulin1 were overexpressed in lung cancer cells.
Conclusions:
- Overexpression of heregulin1, ErbB3, and EGFR mutants drives uncontrolled NSCLC cell proliferation.
- EGFRwt-ErbB3 heterodimers are inhibited by specific EGFR ligands, unlike EGFRmut-ErbB3 heterodimers.
- Targeting heregulin1 or specific EGFR-ErbB3 interactions may offer therapeutic strategies for NSCLC.
Related Concept Videos
Mitogens and the Cell Cycle
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Cells Coordinate Growth and Proliferation
Abnormal Proliferation

